Results 191 to 200 of about 911,773 (309)

Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly

, 2006
Malika Ait‐Goughoulte, Christophe Hourioux, Romuald Patient, Sylvie Trassard, Denys Brand, Philippe Roingeard   +5 more
openalex   +2 more sources

Hepatitis B and C Virus Reactivation Patterns in a Romanian Cohort of Patients with Chronic Lymphoproliferative Disorders [PDF]

, 2019
Violeta Molagic, Raluca Mihăilescu, Cătălin Tilişcan, Cristina Popescu, Ana Maria Vlădăreanu, Remulus Catană, Mihaela Rădulescu, Victoria Aramă, Ștefan Sorin Aramă   +8 more
openalex   +1 more source

Evolving epidemiology of hepatitis C virus.

Clinical Microbiology and Infection, 2011
D. Lavanchy
semanticscholar   +1 more source

A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef, Poonam Shah, Maxwell Hu, Helene Plein, Abhishek Roy, Ravi Sharma, Sarah Mole, Magdalena Blazejczyk, Wendy Cross, Brian Spears, Samuel Pak, Rejbinder Kaur, Robert Elston, Dickens Theodore, Marjan Hezareh, Ahmed Nader   +15 more
wiley   +1 more source

Economic evaluation of an employee health screening program for Hepatitis C virus in Pakistan. [PDF]

Cost Eff Resour Alloc
Qureshi A, Bolas T, Khan UI, Malik AM, Risko N.   +4 more
europepmc   +1 more source

Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex. [PDF]

, 2014
Hai-Chon Lee, Sowmya Narayanan, Sung Jae Park, Seung‐Yong Seong, Young S. Hahn   +4 more
openalex   +1 more source

Gut Dysbiosis Associated With Hepatitis C Virus Infection

Clinical Infectious Diseases, 2018
Takako Inoue, J. Nakayama, K. Moriya, H. Kawaratani, Rie Momoda, Kiyoaki Ito, Etsuko Iio, S. Nojiri, Kei Fujiwara, M. Yoneda, H. Yoshiji, Yasuhito Tanaka   +11 more
semanticscholar   +1 more source

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee, Amy‐Lee Richards, Nageswara Reddy, Brian Beers, Lee Golden, Ronald Kong   +5 more
wiley   +1 more source

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent. [PDF]

J Gen Virol
Mimms JL, Sinnis-Bourozikas A, Felbinger NR, Frumento N, Paul HT, Patel AH, Keck Z, Foung SKH, Law M, Urbanowicz RA, Tarr AW, Ball JK, Pierce BG, Bailey JR.   +13 more
europepmc   +1 more source

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

Science, 2010
R. Lanford, E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, H. Ørum   +7 more
semanticscholar   +1 more source